Lake Resources Announces Exploration of Strategic Alternatives
SYDNEY, May 7, 2025 /PRNewswire/ -- Lake Resources N.L. (ASX: LKE; OTC: LLKKF) ("Lake" or the "Company"), a responsible lithium developer, announced today that its Board of Directors will form a Special Committee composed of all members of the Board...
FancyTech Closes Series B+ to Power AI Personalized Content Solutions in Thailand and Southeast Asia
BANGKOK, May 7, 2025 /PRNewswire/ -- FancyTech, an AI startup specializing in commercial content generation and winner of the 2024 LVMH Innovation Award, has announced the successful close of its Series B+ funding round. The round was co-led by GSR...
Successful Extension of Nucleic Acid Aptamer Pharmacokinetics in Joint Research by Ajinomoto Co., Inc. and RIBOMIC Inc.
AJICAP® Antibody-Drug Conjugate Manufacturing Technology Contributes to Enhanced Efficacy of Antibody Drugs TOKYO, May 7, 2025 /PRNewswire/ -- Ajinomoto Co., Inc. (President: Shigeo Nakamura, Headquarters: Chuo-ku, Tokyo, hereinafter referred to as...
CStone Presents Preclinical Results of CS2011 (EGFR/HER3 bispecific antibody), CS5007 (EGFR/HER3 bispecific ADC), CS5005 (SSTR2 ADC) and CS5006 (ITGB4 ADC) at 2025 AACR
SUZHOU, China, May 7, 2025 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616), an innovation-driven biopharmaceutical company focused on anti-cancer therapies, announced today that poster presentations of preclinical data of CS2011...
Bispecific vs. Bispecific: Innovent Announces First Patient Dosed in the Phase 2 Clinical Study of Efdamrofusp Alfa (IBI302), a First-in-class Anti-VEGF and Anti-Complement Bispecific Fusion Protein for the Treatment of Diabetic Macular Edema
SAN FRANCISCO and SUZHOU, China, May 7, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of...
Everest Medicines Announces NMPA Full Approval of NEFECON® for the Treatment of Primary Immunoglobulin A nephropathy (IgAN) in Adults at Risk of Disease Progression
SHANGHAI, May 7, 2025 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today...
Bellroy, the popular Australian carry brand, releases much-anticipated luggage styles
The brand renowned for solving carry problems extends their expertise to travel, with two wheeled carry-on bags that are lightweight, hard-wearing and repairable in under 10 minutes. MELBOURNE, Australia, May 7, 2025 /PRNewswire/ -- Solving problems...
Blinq Raises $25M Series A to Reimagine the Start of Every Professional Relationship
With over 2.5 million users across 500,000 companies in 189 countries, Blinq is scaling the platform that powers first impressions - and everything after. The new funding will support global expansion, particularly across North America and Europe,...